首页> 外国专利> ALLOSTERIC CONTROL OF NUCLEAR HORMONE RECEPTORS

ALLOSTERIC CONTROL OF NUCLEAR HORMONE RECEPTORS

机译:核激素受体的变构控制

摘要

Heterodimerization is a common paradigm among eucaryotic transcription factors, though it remains unclear how individual monomers contribute to the overall transcriptional activities of the complex. The 9-cis retinoic acid receptor (RXR) serves as a common heterodimerization partner for several nuclear receptors including the thyroid hormone (T3R), retinoic acid (RAR) and vitamin D receptors. A strategy has been devised to examine the transcriptional properties of each receptor individually or when tethered to a heterodimeric partner. It has been found that the intrinsic activity of RXR is masked in RXR-T3R and RXR-RAR heterodimers. In contrast, a novel RXR-Nurr1 heterodimer described herein is highly responsive to RXR ligands, suggesting that different partners exert unique allosteric control over the RXR response. These findings establish a novel 9-cis retinoic acid response pathway and resolve the paradox as to how T3R, RAR and VDR contribute to distinct physiologic pathways while sharing a common RXR subunit.
机译:异二聚化是真核转录因子之间的常见范例,尽管尚不清楚单个单体如何促进复合物的整体转录活性。 9-顺式视黄酸受体(RXR)作为几种核受体(包括甲状腺激素(T3R),视黄酸(RAR)和维生素D受体)的常见异二聚体伙伴。已设计出一种策略来单独检查每个受体的转录特性,或将其拴系在异二聚体伴侣上时进行研究。已经发现RXR的内在活性在RXR-T3R和RXR-RAR异二聚体中被掩盖。相反,本文所述的新型RXR-Nurr1异二聚体对RXR配体高度响应,表明不同的伴侣对RXR响应施加独特的变构控制。这些发现建立了一个新颖的9-顺式视黄酸反应途径,并解决了T3R,RAR和VDR如何在共享一个共同的RXR亚基的同时,如何促进不同的生理途径的悖论。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号